DAB2IP inhibits glucose uptake by modulating HIF-1α ubiquitination under hypoxia in breast cancer

Hongliang Dong1,2, Weiyi Jia1,2,3, Weijian Meng1,2

  • 1Department of GI Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.

Oncogenesis
|June 11, 2024
PubMed

Insights

DAB2IP suppresses glucose uptake in breast cancer by inhibiting HIF-1α signaling. It achieves this by interacting with STUB1, leading to HIF-1α degradation and reduced tumor progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Metabolism

Background:

  • Metabolic reprogramming is crucial in tumor biology, with glucose metabolism frequently altered in breast cancer.
  • DAB2IP is a known tumor suppressor in breast cancer, but its role in regulating glucose uptake is not fully understood.

Purpose of the Study:

  • To investigate the mechanism by which DAB2IP regulates glucose uptake in breast cancer cells.
  • To elucidate the role of DAB2IP in hypoxia-driven metabolic changes and tumor progression.

Main Methods:

  • Investigated DAB2IP's effect on glucose uptake in breast cancer cells under hypoxia.
  • Utilized co-immunoprecipitation to study protein interactions between DAB2IP, STUB1, and HIF-1α.
  • Assessed HIF-1α ubiquitylation and degradation.
  • Examined the impact of DAB2IP's PER domain deletion on cellular metabolism.

Main Results:

  • DAB2IP inhibited glucose uptake in breast cancer cells under hypoxia by suppressing HIF-1α signaling.
  • DAB2IP interacted with STUB1 via its PER domain, promoting HIF-1α ubiquitylation and degradation.
  • Deletion of the PER domain abolished DAB2IP's inhibitory effects on glucose uptake, ATP, and lactic acid production.

Conclusions:

  • DAB2IP plays a significant role in regulating cancer-related glucose metabolism.
  • A novel mechanism involving STUB1-mediated HIF-1α degradation regulated by DAB2IP was identified in breast cancer.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
13.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K